期刊
NATURE BIOTECHNOLOGY
卷 32, 期 5, 页码 479-U202出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2892
关键词
-
资金
- Conquer Cancer Foundation Young Investigator Award
- US National Institutes of Health (DF/HCC SPORE) [5P50CA100707-10]
- Wong Family Award
- National Science Foundation
- Prostate Cancer Foundation Young Investigator Award
- Department of Defense Physician Scientist Training Award
Comprehensive analyses of cancer genomes promise to inform prognoses and precise cancer treatments. A major barrier, however, is inaccessibility of metastatic tissue. A potential solution is to characterize circulating tumor cells (CTCs), but this requires overcoming the challenges of isolating rare cells and sequencing low-input material. Here we report an integrated process to isolate, qualify and sequence whole exomes of CTCs with high fidelity using a census-based sequencing strategy. Power calculations suggest that mapping of > 99.995% of the standard exome is possible in CTCs. We validated our process in two patients with prostate cancer, including one for whom we sequenced CTCs, a lymph node metastasis and nine cores of the primary tumor. Fifty-one of 73 CTC mutations (70%) were present in matched tissue. Moreover, we identified 10 early trunk and 56 metastatic trunk mutations in the non-CTC tumor samples and found 90% and 73% of these mutations, respectively, in CTC exomes. This study establishes a foundation for CTC genomics in the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据